FAIRBAIRN EMILY 4

What Happened

• Emily Fairbairn, a director of Movano, received three awards reported on Form 4: 200,000 derivative shares (granted 2026-03-18), and 9.232 and 2,063.823 derivative shares (granted 2026-03-19). All were reported as acquisitions at $0, for an aggregate of 202,073.055 units. These transactions are awards/grants (derivative instruments), not open-market purchases or sales.

Key Details

• Transaction dates and prices: 2026-03-18 (200,000 @ $0); 2026-03-19 (9.232 @ $0; 2,063.823 @ $0). All coded as "A" (award/grant).
• Shares owned after the transactions: not specified in the provided summary (not reported here).
• Relevant footnotes from the filing:
  • F1: One award is an option that vests in three equal annual installments and will become exercisable upon shareholder approval.
  • F2: Series B preferred stock automatically converts to common on 2026-03-31 at a 1:1,000 ratio.
  • F3: Some preferred shares were received in exchange for the Reporting Person’s Corvex, Inc. securities under the March 19, 2026 merger agreement.
  • F4: The preferred stock is perpetual (no expiration).
  • F5: Series C preferred converts at 1:1,000 upon shareholder approval per Nasdaq rules.
• Timeliness: Form filed 2026-03-19 covering transactions on 2026-03-18 and 2026-03-19; filing appears timely (no late‑filing flag reported).

Context

• These were awards/derivative grants (options and/or preferred shares), not sales or open‑market buys. Options noted will vest over time and require shareholder approval to become exercisable; some preferreds convert to common stock at specified ratios (which would increase common share count if/when conversion occurs or is approved).
• Awards and conversion-related grants are often part of compensation, merger consideration, or capital-structure actions and do not directly indicate the insider is buying or selling based on near‑term sentiment. Monitor future Form 4/Form 5 filings for exercises, conversions, or sales that realize value.